Everything felt fine until the third month when her dose increased to 1.7 mg
Some people seem to be particularly responsive to GLP-1 therapy, potentially due to genetic factors affecting GLP-1 receptor density or sensitivity
Austin K, Imam NA, Pintar JE, Brubaker PL
Phase 2 clinical research published in 2023 documented metabolic effects exceeding those reported for any prior incretin agonist, establishing retatrutide as a benchmark reference compound for triple-receptor pharmacology and as a focal point for the next generation of metabolic peptide research
Some studies suggest that these medications may help reduce neuroinflammation, enhance memory, and slow cognitive decline , making them a possible therapeutic option for Alzheimers and Parkinsons disease (Holscher, 2020)
Fc fusion to glucagon-like peptide-1 inhibits degradation by human DPP-IV, increasing its half-life in serum and inducing a potent activity for human GLP-1 receptor activation
